Thaiger Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 5.13 M
- Company Age 10 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 58.45%
- Profit Growth 38.70%
- Ebitda 55.48%
- Net Worth 20.04%
- Total Assets 18.52%
About Thaiger Pharma
Thaiger Pharma Private Limited (TPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 17 February 2014 and has a history of Ten years and 11 months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.13 M, as per Ministry of Corporate Affairs (MCA) records.
Irfan Dhorajiwala and Aftab Attarwala serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100MH2014PTC253312
-
Company No.
253312
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Feb 2014
-
Date of AGM
24 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
What products or services does Thaiger Pharma Private Limited offer?
Thaiger Pharma Private Limited offers a wide range of products and services, including Injectable Products.
Who are the key members and board of directors at Thaiger Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Irfan Dhorajiwala
|
Director | 17-Feb-2014 | Current |
|
Aftab Attarwala
|
Director | 27-Mar-2023 | Current |
Financial Performance of Thaiger Pharma.
Thaiger Pharma Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 58.45% increase. The company also saw a substantial improvement in profitability, with a 38.7% increase in profit. The company's net worth Soared by an impressive increase of 20.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Thaiger Pharma?
Unlock access to Thaiger Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Thaiger Nutraceuticals Private LimitedIrfan Dhorajiwala is a mutual person
-
Nova Laboratories Private LimitedIrfan Dhorajiwala is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Thaiger Pharma?
Unlock and access historical data on people associated with Thaiger Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Thaiger Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thaiger Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
